12 31/03/2023 2023-03-31 false false false false false false false false false false true false false true false false false false false true false 2022-04-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 07211938 2022-04-01 2023-03-31 07211938 2023-03-31 07211938 2022-03-31 07211938 2021-04-01 2022-03-31 07211938 2022-03-31 07211938 core:FurnitureFittingsToolsEquipment 2022-04-01 2023-03-31 07211938 bus:RegisteredOffice 2022-04-01 2023-03-31 07211938 bus:OrdinaryShareClass3 2022-04-01 2023-03-31 07211938 bus:OrdinaryShareClass4 2022-04-01 2023-03-31 07211938 bus:LeadAgentIfApplicable 2022-04-01 2023-03-31 07211938 bus:Director1 2022-04-01 2023-03-31 07211938 bus:CompanySecretary1 2022-04-01 2023-03-31 07211938 core:FurnitureFittingsToolsEquipment 2022-03-31 07211938 core:FurnitureFittingsToolsEquipment 2023-03-31 07211938 core:WithinOneYear 2023-03-31 07211938 core:WithinOneYear 2022-03-31 07211938 core:ShareCapital 2023-03-31 07211938 core:ShareCapital 2022-03-31 07211938 core:RetainedEarningsAccumulatedLosses 2023-03-31 07211938 core:RetainedEarningsAccumulatedLosses 2022-03-31 07211938 bus:OrdinaryShareClass1 core:ShareCapital 2023-03-31 07211938 bus:OrdinaryShareClass1 core:ShareCapital 2022-03-31 07211938 bus:OrdinaryShareClass2 core:ShareCapital 2023-03-31 07211938 bus:OrdinaryShareClass2 core:ShareCapital 2022-03-31 07211938 core:FurnitureFittingsToolsEquipment 2022-03-31 07211938 bus:Director1 2022-03-31 07211938 bus:Director1 2023-03-31 07211938 bus:Director1 2021-03-31 07211938 bus:Director1 2022-03-31 07211938 bus:Director1 2021-04-01 2022-03-31 07211938 bus:SmallEntities 2022-04-01 2023-03-31 07211938 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 07211938 bus:FullAccounts 2022-04-01 2023-03-31 07211938 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 07211938 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31
Company registration number: 07211938
Dr. Esa Surgery Limited
Unaudited filleted financial statements
31 March 2023
Dr. Esa Surgery Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
Dr. Esa Surgery Limited
Directors and other information
Director Dr Badrul Hisham Esa
Secretary Dr Badrul Hisham Esa
Company number 07211938
Registered office Crossens Way Business Park
Crossens Way
Southport
Merseyside
PR9 9LY
Accountants Forshaws Accountants Limited
Crossens Way Business Park
Crossens Way
Southport
Merseyside
PR9 9LY
Dr. Esa Surgery Limited
Chartered accountants report to the director on the preparation of the
unaudited statutory financial statements of Dr. Esa Surgery Limited
Year ended 31 March 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Dr. Esa Surgery Limited for the year ended 31 March 2023 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance.
This report is made solely to the director of Dr. Esa Surgery Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Dr. Esa Surgery Limited and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Dr. Esa Surgery Limited and its director as a body for our work or for this report.
It is your duty to ensure that Dr. Esa Surgery Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Dr. Esa Surgery Limited. You consider that Dr. Esa Surgery Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Dr. Esa Surgery Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Forshaws Accountants Limited
Chartered Accountants
Crossens Way Business Park
Crossens Way
Southport
Merseyside
PR9 9LY
9 November 2023
Dr. Esa Surgery Limited
Statement of financial position
31 March 2023
2023 2022
Note £ £ £ £
Fixed assets
Tangible assets 5 9,398 10,261
_______ _______
9,398 10,261
Current assets
Debtors 6 224,115 158,789
Cash at bank and in hand 127,468 167,647
_______ _______
351,583 326,436
Creditors: amounts falling due
within one year 7 ( 76,017) ( 116,287)
_______ _______
Net current assets 275,566 210,149
_______ _______
Total assets less current liabilities 284,964 220,410
_______ _______
Net assets 284,964 220,410
_______ _______
Capital and reserves
Called up share capital 8 100 100
Profit and loss account 284,864 220,310
_______ _______
Shareholders funds 284,964 220,410
_______ _______
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 09 November 2023 , and are signed on behalf of the board by:
Dr Badrul Hisham Esa
Director
Company registration number: 07211938
Dr. Esa Surgery Limited
Notes to the financial statements
Year ended 31 March 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Crossens Way Business Park, Crossens Way, Southport, Merseyside, PR9 9LY.
The principal activity of the company is that of providing general medical services.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the annual report and accounts. Should the existing facilities not be sufficient to fund the company's working capital for the period ending 12 months from the date of approval of these financial statements, the Directors have considered alternative sources of financing, including, but not restricted to, additional financial support from its shareholders, and understand that these funds would provide sufficient resource to meet any shortfall which may arise under agreed facilities.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the services is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fittings fixtures and equipment - 15 % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 12 (2022: 11 ).
5. Tangible assets
Fixtures, fittings and equipment Total
£ £
Cost
At 1 April 2022 27,116 27,116
Additions 796 796
_______ _______
At 31 March 2023 27,912 27,912
_______ _______
Depreciation
At 1 April 2022 16,855 16,855
Charge for the year 1,659 1,659
_______ _______
At 31 March 2023 18,514 18,514
_______ _______
Carrying amount
At 31 March 2023 9,398 9,398
_______ _______
At 31 March 2022 10,261 10,261
_______ _______
6. Debtors
2023 2022
£ £
Trade debtors 29,825 16,201
Other debtors 194,290 142,588
_______ _______
224,115 158,789
_______ _______
7. Creditors: amounts falling due within one year
2023 2022
£ £
Bank loans and overdrafts - 7
Trade creditors 18,640 30,457
Corporation tax 50,356 54,496
Social security and other taxes 3,398 4,413
Other creditors 3,623 26,914
_______ _______
76,017 116,287
_______ _______
8. Called up share capital
2023 2022
No £ No £
Ordinary A shares of £ 1.00 each 50 50 50 50
Ordinary B shares of £ 1.00 each 25 25 50 50
Ordinary C shares shares of £ 1.00 each 12.5 12.5 - -
Ordinary D shares shares of £ 1.00 each 12.5 12.5 - -
_______ _______ _______ _______
100 100 100 100
_______ _______ _______ _______
9. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2023
Balance brought forward Dividends voted Drawings Balance carried forward
£ £ £ £
Dr Badrul Hisham Esa 141,252 ( 145,000) 198,038 194,290
_______ _______ _______ _______
2022
Balance brought forward Dividends voted Drawings Balance carried forward
£ £ £ £
Dr Badrul Hisham Esa 49,884 ( 150,612) 241,980 141,252
_______ _______ _______ _______
10. Controlling party
The company is not under the control of any one individual.